QualifyHQ Logo

Alprotec

Alzprotect is a biopharmaceutical company that develops drug candidates, from their discovery to clinical trials, for the treatment of neurodegenerative diseases including Alzheimer’s disease (AD) and tauopathies such as Progressive Supranuclear Palsy (PSP).

Founded

2007

Revenue

$1.0M - $2.5M

Funding

$20.2M

View similar companies

Qualify this Company in

minutes

While other tools waste time, we help you qualify better-fit companies in minutes, so your pipeline stays healthy, your team stays productive, and your deals move faster.

Start free trial

Start 7-Day Free Trial